• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin" [Bioorg. Med. Chem. Lett. 32 (2021) 127683].

作者信息

Kahlon Gulbag, Lira Rogelio, Masvlov Nikolay, Pompa Emmett, Brar Nimrat, Eagon Scott, Anderson Marc O, Andaya Armann, Chance Jeff P, Fejzic Hannah, Keniston Aaron, Huynh Ngoc, Celis Nohemy, Vidal Brian, Trieu Nicholas, Rodriguez Paulina, Mallari Jeremy P

机构信息

Department of Chemistry and Biochemistry, California State University, San Bernardino, USA.

Department of Chemistry and Biochemistry, California Polytechnic State University, San Luis Obispo, USA.

出版信息

Bioorg Med Chem Lett. 2021 Apr 1;37:127836. doi: 10.1016/j.bmcl.2021.127836. Epub 2021 Feb 13.

DOI:10.1016/j.bmcl.2021.127836
PMID:33588181
Abstract
摘要

相似文献

1
Corrigendum to "Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin" [Bioorg. Med. Chem. Lett. 32 (2021) 127683].《针对falcilysin的强效哌嗪衍生异羟肟酸抑制剂的结构导向开发》的勘误[《生物有机与药物化学快报》32 (2021) 127683]
Bioorg Med Chem Lett. 2021 Apr 1;37:127836. doi: 10.1016/j.bmcl.2021.127836. Epub 2021 Feb 13.
2
Corrigendum to "Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase" [Bioorg. Med. Chem. Lett. 29 (2019) 1918-1921].
Bioorg Med Chem Lett. 2019 Sep 1;29(17):2525. doi: 10.1016/j.bmcl.2019.07.032. Epub 2019 Jul 25.
3
Corrigendum to "Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay" [Bioorg. Med. Chem. Lett. 25 (2015) 2505-2509].《使用快速PK筛选测定法评估二氟唾液酸前药（强效病毒神经氨酸酶抑制剂）的口服生物利用度》的勘误[《生物有机与药物化学快报》25 (2015) 2505 - 2509]
Bioorg Med Chem Lett. 2016 Jul 2. doi: 10.1016/j.bmcl.2016.06.068.
4
Corrigendum to "Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors" [Bioorg. Med. Chem. Lett. 60 (2022) 128549].
Bioorg Med Chem Lett. 2022 Sep 15;72:128856. doi: 10.1016/j.bmcl.2022.128856. Epub 2022 Jun 18.
5
Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial protease.哌嗪基羟肟酸类抑制剂对抗裂殖体，一种疟原虫必需的蛋白酶的开发。
Bioorg Med Chem Lett. 2018 Jun 1;28(10):1846-1848. doi: 10.1016/j.bmcl.2018.04.010. Epub 2018 Apr 19.
6
Corrigendum to 'Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors' [Bioorg. Med. Chem. Lett. 29 (2019) 126675].
Bioorg Med Chem Lett. 2020 Jan 15;30(2):126771. doi: 10.1016/j.bmcl.2019.126771. Epub 2019 Dec 16.
7
Corrigendum to "Metabolism-based structure optimization: Discovery of a potent and orally available tyrosine kinase ALK inhibitor bearing the tetracyclic benzo[b]carbazolone core" [Bioorg. Med. Chem. Lett. 26 (2016) 5399-5402].
Bioorg Med Chem Lett. 2020 Feb 15;30(4):126931. doi: 10.1016/j.bmcl.2019.126931. Epub 2020 Jan 2.
8
Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].《新型苯甲酰胺衍生物作为高效的Smoothened拮抗剂的合成及生物学评价》的勘误[《生物有机与药物化学快报》24/5 (2014) 1426 - 1431]
Bioorg Med Chem Lett. 2016 Sep 15;26(18):4558. doi: 10.1016/j.bmcl.2015.06.051. Epub 2016 Aug 16.
9
Corrigendum to "Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research" [Bioorg. Med. Chem. Lett. 29 (2019) 2016-2024].
Bioorg Med Chem Lett. 2021 Aug 1;45:128140. doi: 10.1016/j.bmcl.2021.128140. Epub 2021 May 27.
10
Corrigendum to "Investigation of biaryl heterocycles as inhibitors of Wee1 kinase" [Bioorg. Med. Chem. Lett. 29 (2019) 1481-1486].《关于“作为Wee1激酶抑制剂的联芳基杂环的研究”的勘误》[《生物有机与药物化学快报》29 (2019) 1481 - 1486]
Bioorg Med Chem Lett. 2020 Feb 15;30(4):126895. doi: 10.1016/j.bmcl.2019.126895. Epub 2020 Jan 8.